CODX Stock Summary and Trading Ideas (Co-Diagnostics | NASDAQ:CODX)

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

What symbol and exchange does Co-Diagnostics shares trade?

Co-Diagnostics trades on the NASDAQ stock market under the symbol CODX.

What is Co-Diagnostics stock price doing today?

As of August 26, 2026, CODX stock price climbed to $1.25 with 45,927 million shares trading.

What is Co-Diagnostics's Beta?

CODX has a beta of 5.63, meaning it tends to be more sensitive to market movements. CODX has a correlation of 0.08 to the broad based SPY ETF.

How much is Co-Diagnostics worth?

CODX has a market cap of $7.82 million. This is considered a Sub-Micro Cap stock.

How much money does Co-Diagnostics make?

Last quarter Co-Diagnostics reported $166,131 in Revenue and -$1.46 earnings per share. This fell short of revenue expectation by $-33,869 and exceeded earnings estimates by $1.54.

What are the top ETFs holding Co-Diagnostics?

The top ETF exchange traded funds that CODX belongs to (by Net Assets): VXF.

What are the support and resistance levels for Co-Diagnostics (CODX)?

CODX support price is $1.09 and resistance is $1.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CODX shares will trade within this expected range on the day.